Good Protection but Excessive Pulmonary Inflammation in Balb/C Mice Vaccinated with Mycobacterium Bovis Mce-2A Mutant after Challenge with Homologous Strains

Autores
Alfonseca Silva, Edgar; Cataldi, Angel Adrian; Bigi, Fabiana; Hernández Pando, Rogelio
Año de publicación
2012
Idioma
inglés
Tipo de recurso
artículo
Estado
versión publicada
Descripción
Tuberculosis (TB) remains a major threat to public and veterinary health. Zoonotic TB (caused by Mycobacterium bovis) is present in wild animals and cattle in most developing countries, and M. bovis is also able to infect humans on a worldwide basis. Thus, the high incidence of bovine TB is a major economic problem and an additional risk to human health, being the development of new vaccines to prevent both human and bovine TB urgent and a major challenge. The aims of the present study were to characterize the pathogenicity and immunogenicity of M. bovis mce2A mutant in BALB/c mice, and then evaluate its potential as vaccine. Mutant M. bovis mce2A produced limited tissue damage (pneumonia) and lower bacilli burdens than its parental strain when administered in high dose by intratracheal inoculation, and showed limited dissemination when used as subcutaneous vaccine. Challenge experiments using low, middle and highly virulent M. tuberculosis or M. bovis strains showed similar protection conferred by mce-2 mutant than BCG. Interestingly, vaccinated animals showed low bacilli loads but high inflammatory response when were challenged with M. bovis strains, while vaccinated mice challenged with M. tuberculosis exhibited low bacilli burdens and scarce inflammation. Thus, in spite of the high genome homology between M. tuberculosis and M. bovis, it seems that there is higher antigenic recognition and in consequence extensive inflammatory response when the strain used as vaccine is homologous to the challenge strain, in this case M. bovis.
Fil: Alfonseca Silva, Edgar. Universidad Nacional Autónoma de México; México
Fil: Cataldi, Angel Adrian. Instituto Nacional de Tecnología Agropecuaria. Centro de Investigación en Ciencias Veterinarias y Agronómicas. Instituto de Agrobiotecnología y Biología Molecular. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Parque Centenario. Instituto de Agrobiotecnología y Biología Molecular; Argentina
Fil: Bigi, Fabiana. Instituto Nacional de Tecnología Agropecuaria. Centro de Investigación en Ciencias Veterinarias y Agronómicas. Instituto de Agrobiotecnología y Biología Molecular. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Parque Centenario. Instituto de Agrobiotecnología y Biología Molecular; Argentina
Fil: Hernández Pando, Rogelio. Instituto Nacional de Ciencias Médicas y Nutrición “Salvador Zubirán”; México
Materia
MCE2
Mycobacterium bovis
Tuberculosis
Mutant
Nivel de accesibilidad
acceso abierto
Condiciones de uso
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
Repositorio
CONICET Digital (CONICET)
Institución
Consejo Nacional de Investigaciones Científicas y Técnicas
OAI Identificador
oai:ri.conicet.gov.ar:11336/196560
Acceder
id CONICETDig_c1829eaed9a5f29a07f882019f03862e
oai_identifier_str oai:ri.conicet.gov.ar:11336/196560
network_acronym_str CONICETDig
repository_id_str 3498
network_name_str CONICET Digital (CONICET)
spelling Good Protection but Excessive Pulmonary Inflammation in Balb/C Mice Vaccinated with Mycobacterium Bovis Mce-2A Mutant after Challenge with Homologous StrainsAlfonseca Silva, EdgarCataldi, Angel AdrianBigi, FabianaHernández Pando, RogelioMCE2Mycobacterium bovisTuberculosisMutanthttps://purl.org/becyt/ford/1.6https://purl.org/becyt/ford/1Tuberculosis (TB) remains a major threat to public and veterinary health. Zoonotic TB (caused by Mycobacterium bovis) is present in wild animals and cattle in most developing countries, and M. bovis is also able to infect humans on a worldwide basis. Thus, the high incidence of bovine TB is a major economic problem and an additional risk to human health, being the development of new vaccines to prevent both human and bovine TB urgent and a major challenge. The aims of the present study were to characterize the pathogenicity and immunogenicity of M. bovis mce2A mutant in BALB/c mice, and then evaluate its potential as vaccine. Mutant M. bovis mce2A produced limited tissue damage (pneumonia) and lower bacilli burdens than its parental strain when administered in high dose by intratracheal inoculation, and showed limited dissemination when used as subcutaneous vaccine. Challenge experiments using low, middle and highly virulent M. tuberculosis or M. bovis strains showed similar protection conferred by mce-2 mutant than BCG. Interestingly, vaccinated animals showed low bacilli loads but high inflammatory response when were challenged with M. bovis strains, while vaccinated mice challenged with M. tuberculosis exhibited low bacilli burdens and scarce inflammation. Thus, in spite of the high genome homology between M. tuberculosis and M. bovis, it seems that there is higher antigenic recognition and in consequence extensive inflammatory response when the strain used as vaccine is homologous to the challenge strain, in this case M. bovis.Fil: Alfonseca Silva, Edgar. Universidad Nacional Autónoma de México; MéxicoFil: Cataldi, Angel Adrian. Instituto Nacional de Tecnología Agropecuaria. Centro de Investigación en Ciencias Veterinarias y Agronómicas. Instituto de Agrobiotecnología y Biología Molecular. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Parque Centenario. Instituto de Agrobiotecnología y Biología Molecular; ArgentinaFil: Bigi, Fabiana. Instituto Nacional de Tecnología Agropecuaria. Centro de Investigación en Ciencias Veterinarias y Agronómicas. Instituto de Agrobiotecnología y Biología Molecular. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Parque Centenario. Instituto de Agrobiotecnología y Biología Molecular; ArgentinaFil: Hernández Pando, Rogelio. Instituto Nacional de Ciencias Médicas y Nutrición “Salvador Zubirán”; MéxicoOMICS Publishing Group2012-05info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/196560Alfonseca Silva, Edgar; Cataldi, Angel Adrian; Bigi, Fabiana; Hernández Pando, Rogelio; Good Protection but Excessive Pulmonary Inflammation in Balb/C Mice Vaccinated with Mycobacterium Bovis Mce-2A Mutant after Challenge with Homologous Strains; OMICS Publishing Group; Mycobacterial Diseases; 02; 03; 5-2012; 1-82161-1068CONICET DigitalCONICETenginfo:eu-repo/semantics/altIdentifier/url/Good Protection but Excessive Pulmonary Inflammation in Balb/C Mice Vaccinated with Mycobacterium Bovis Mce-2A Mutant after Challenge with Homologous Strainsinfo:eu-repo/semantics/altIdentifier/doi/10.4172/2161-1068.1000111info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-09-03T10:10:55Zoai:ri.conicet.gov.ar:11336/196560instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-09-03 10:10:55.836CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse
dc.title.none.fl_str_mv Good Protection but Excessive Pulmonary Inflammation in Balb/C Mice Vaccinated with Mycobacterium Bovis Mce-2A Mutant after Challenge with Homologous Strains
title Good Protection but Excessive Pulmonary Inflammation in Balb/C Mice Vaccinated with Mycobacterium Bovis Mce-2A Mutant after Challenge with Homologous Strains
spellingShingle Good Protection but Excessive Pulmonary Inflammation in Balb/C Mice Vaccinated with Mycobacterium Bovis Mce-2A Mutant after Challenge with Homologous Strains
Alfonseca Silva, Edgar
MCE2
Mycobacterium bovis
Tuberculosis
Mutant
title_short Good Protection but Excessive Pulmonary Inflammation in Balb/C Mice Vaccinated with Mycobacterium Bovis Mce-2A Mutant after Challenge with Homologous Strains
title_full Good Protection but Excessive Pulmonary Inflammation in Balb/C Mice Vaccinated with Mycobacterium Bovis Mce-2A Mutant after Challenge with Homologous Strains
title_fullStr Good Protection but Excessive Pulmonary Inflammation in Balb/C Mice Vaccinated with Mycobacterium Bovis Mce-2A Mutant after Challenge with Homologous Strains
title_full_unstemmed Good Protection but Excessive Pulmonary Inflammation in Balb/C Mice Vaccinated with Mycobacterium Bovis Mce-2A Mutant after Challenge with Homologous Strains
title_sort Good Protection but Excessive Pulmonary Inflammation in Balb/C Mice Vaccinated with Mycobacterium Bovis Mce-2A Mutant after Challenge with Homologous Strains
dc.creator.none.fl_str_mv Alfonseca Silva, Edgar
Cataldi, Angel Adrian
Bigi, Fabiana
Hernández Pando, Rogelio
author Alfonseca Silva, Edgar
author_facet Alfonseca Silva, Edgar
Cataldi, Angel Adrian
Bigi, Fabiana
Hernández Pando, Rogelio
author_role author
author2 Cataldi, Angel Adrian
Bigi, Fabiana
Hernández Pando, Rogelio
author2_role author
author
author
dc.subject.none.fl_str_mv MCE2
Mycobacterium bovis
Tuberculosis
Mutant
topic MCE2
Mycobacterium bovis
Tuberculosis
Mutant
purl_subject.fl_str_mv https://purl.org/becyt/ford/1.6
https://purl.org/becyt/ford/1
dc.description.none.fl_txt_mv Tuberculosis (TB) remains a major threat to public and veterinary health. Zoonotic TB (caused by Mycobacterium bovis) is present in wild animals and cattle in most developing countries, and M. bovis is also able to infect humans on a worldwide basis. Thus, the high incidence of bovine TB is a major economic problem and an additional risk to human health, being the development of new vaccines to prevent both human and bovine TB urgent and a major challenge. The aims of the present study were to characterize the pathogenicity and immunogenicity of M. bovis mce2A mutant in BALB/c mice, and then evaluate its potential as vaccine. Mutant M. bovis mce2A produced limited tissue damage (pneumonia) and lower bacilli burdens than its parental strain when administered in high dose by intratracheal inoculation, and showed limited dissemination when used as subcutaneous vaccine. Challenge experiments using low, middle and highly virulent M. tuberculosis or M. bovis strains showed similar protection conferred by mce-2 mutant than BCG. Interestingly, vaccinated animals showed low bacilli loads but high inflammatory response when were challenged with M. bovis strains, while vaccinated mice challenged with M. tuberculosis exhibited low bacilli burdens and scarce inflammation. Thus, in spite of the high genome homology between M. tuberculosis and M. bovis, it seems that there is higher antigenic recognition and in consequence extensive inflammatory response when the strain used as vaccine is homologous to the challenge strain, in this case M. bovis.
Fil: Alfonseca Silva, Edgar. Universidad Nacional Autónoma de México; México
Fil: Cataldi, Angel Adrian. Instituto Nacional de Tecnología Agropecuaria. Centro de Investigación en Ciencias Veterinarias y Agronómicas. Instituto de Agrobiotecnología y Biología Molecular. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Parque Centenario. Instituto de Agrobiotecnología y Biología Molecular; Argentina
Fil: Bigi, Fabiana. Instituto Nacional de Tecnología Agropecuaria. Centro de Investigación en Ciencias Veterinarias y Agronómicas. Instituto de Agrobiotecnología y Biología Molecular. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Parque Centenario. Instituto de Agrobiotecnología y Biología Molecular; Argentina
Fil: Hernández Pando, Rogelio. Instituto Nacional de Ciencias Médicas y Nutrición “Salvador Zubirán”; México
description Tuberculosis (TB) remains a major threat to public and veterinary health. Zoonotic TB (caused by Mycobacterium bovis) is present in wild animals and cattle in most developing countries, and M. bovis is also able to infect humans on a worldwide basis. Thus, the high incidence of bovine TB is a major economic problem and an additional risk to human health, being the development of new vaccines to prevent both human and bovine TB urgent and a major challenge. The aims of the present study were to characterize the pathogenicity and immunogenicity of M. bovis mce2A mutant in BALB/c mice, and then evaluate its potential as vaccine. Mutant M. bovis mce2A produced limited tissue damage (pneumonia) and lower bacilli burdens than its parental strain when administered in high dose by intratracheal inoculation, and showed limited dissemination when used as subcutaneous vaccine. Challenge experiments using low, middle and highly virulent M. tuberculosis or M. bovis strains showed similar protection conferred by mce-2 mutant than BCG. Interestingly, vaccinated animals showed low bacilli loads but high inflammatory response when were challenged with M. bovis strains, while vaccinated mice challenged with M. tuberculosis exhibited low bacilli burdens and scarce inflammation. Thus, in spite of the high genome homology between M. tuberculosis and M. bovis, it seems that there is higher antigenic recognition and in consequence extensive inflammatory response when the strain used as vaccine is homologous to the challenge strain, in this case M. bovis.
publishDate 2012
dc.date.none.fl_str_mv 2012-05
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
http://purl.org/coar/resource_type/c_6501
info:ar-repo/semantics/articulo
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv http://hdl.handle.net/11336/196560
Alfonseca Silva, Edgar; Cataldi, Angel Adrian; Bigi, Fabiana; Hernández Pando, Rogelio; Good Protection but Excessive Pulmonary Inflammation in Balb/C Mice Vaccinated with Mycobacterium Bovis Mce-2A Mutant after Challenge with Homologous Strains; OMICS Publishing Group; Mycobacterial Diseases; 02; 03; 5-2012; 1-8
2161-1068
CONICET Digital
CONICET
url http://hdl.handle.net/11336/196560
identifier_str_mv Alfonseca Silva, Edgar; Cataldi, Angel Adrian; Bigi, Fabiana; Hernández Pando, Rogelio; Good Protection but Excessive Pulmonary Inflammation in Balb/C Mice Vaccinated with Mycobacterium Bovis Mce-2A Mutant after Challenge with Homologous Strains; OMICS Publishing Group; Mycobacterial Diseases; 02; 03; 5-2012; 1-8
2161-1068
CONICET Digital
CONICET
dc.language.none.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv info:eu-repo/semantics/altIdentifier/url/Good Protection but Excessive Pulmonary Inflammation in Balb/C Mice Vaccinated with Mycobacterium Bovis Mce-2A Mutant after Challenge with Homologous Strains
info:eu-repo/semantics/altIdentifier/doi/10.4172/2161-1068.1000111
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
eu_rights_str_mv openAccess
rights_invalid_str_mv https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
dc.format.none.fl_str_mv application/pdf
application/pdf
application/pdf
dc.publisher.none.fl_str_mv OMICS Publishing Group
publisher.none.fl_str_mv OMICS Publishing Group
dc.source.none.fl_str_mv reponame:CONICET Digital (CONICET)
instname:Consejo Nacional de Investigaciones Científicas y Técnicas
reponame_str CONICET Digital (CONICET)
collection CONICET Digital (CONICET)
instname_str Consejo Nacional de Investigaciones Científicas y Técnicas
repository.name.fl_str_mv CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas
repository.mail.fl_str_mv dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar
_version_ 1842270137722339328
score 13.13397

Publicaciones similares